Browsing Tag
Europe
116 posts
ACROBiosystems just removed a quiet bottleneck in drug discovery. Will biopharma buyers notice?
Biopharma wants faster R&D, but compliance still slows labs. ACROBiosystems is turning HEK293 licensing into a workflow advantage.
May 10, 2026
What FY27 guidance means for Infosys (NSE: INFY) investors now
INFY has profit and AI ambition, but guidance is cautious. FY27 will test whether Infosys can turn stability into a recovery trade.
May 9, 2026
A 5GW AI power play: Is IREN Limited building Europe’s next data center platform?
IREN Limited expands into Europe with a Spain AI infrastructure acquisition that boosts its power portfolio to 5GW. Find out what it means.
May 9, 2026
iGarden pushes AI-powered backyard ecosystem into Europe’s energy efficiency race
Europe is squeezing household energy waste. iGarden wants the backyard to become the next AI-managed efficiency frontier.
May 7, 2026
Equinor brings Eirin field online as Norway accelerates marginal-field strategy to defend Europe’s gas supply
A field abandoned in 1978 is now feeding Europe's gas grid. Equinor's Eirin tells you what Norway's North Sea strategy looks like in 2026.
May 6, 2026
Ballard Power Systems (BLDP) stock jumps as Solaris backs FCmove-SC for next hydrogen bus platform
Hydrogen buses need better economics. Solaris just backed Ballard Power Systems’ FCmove-SC. Can BLDP turn validation into scale?
May 6, 2026
Is The Estée Lauder Companies quietly rebuilding its skin care future through 111SKIN?
The Estée Lauder Companies backs 111SKIN as clinical luxury skin care gains momentum. Find out why this minority stake matters.
May 2, 2026
Telix Pharmaceuticals (TLX) gains European review momentum for TLX101-Px brain cancer imaging candidate
Telix has a glioma imaging gap to fill. Europe’s TLX101-Px review could test whether radiopharma can move beyond prostate cancer.
May 1, 2026
Unilever PLC (LSE: ULVR) reports 3.8% underlying sales growth as Dove, India and Home Care drive Q1
Unilever volumes are recovering, but currency and portfolio risk remain. Can ULVR turn simplification into a cleaner growth story?
April 30, 2026
Adidas Q1 2026 beats Street with €705m operating profit and 14% currency-neutral growth as ADS Xetra rallies 9% on FIFA World Cup tailwind
Adidas beat Q1 2026 consensus with €705m operating profit, but held 2026 guidance flat. The unbooked €300m tariff item is the real story for ADS investors.
April 30, 2026